A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

查看全文 作　　者：Cynthia;X.;Ma;Matthew;J.;C.;Ellis;Gina;R.;Petroni;Zhanfang;Guo;Shi-rong;Cai;Christine;E.;Ryan;A.;Craig;Lockhart;Michael;J.;Naughton;Timothy;J.;Pluard;Christiana;M.;Brenin;Joel;Picus;Allison;N.;Creekmore;Tibu;Mwandoro;Erin;R.;Yarde;Jerry;Reed;Mark;Ebbert;P 出　　处：《Breast Cancer Research and Treatment》索引2013年第2期,共0页